Natco Pharma Limited Declares ₹1.50 Interim Dividend for FY2027

Natco Pharma Limited declared a ₹1.50 per-equity-share interim dividend for FY2027 on 14 August 2026, fixing 20 August 2026 as both the ex-date and record date. The announcement sets the shareholder eligibility date and indicates that payment was scheduled to start from 26 August 2026.

What did Natco Pharma announce for FY2027?

Natco Pharma declared an interim dividend of ₹1.50 on each equity share of face value ₹2 for the financial year 2026-27. The company described the dividend as 75% of the face value, based on its ₹2 per-share equity capital denomination.

The declaration was made on 14 August 2026. The available dividend data identifies this as the latest dividend declaration, and lists its dividend yield at the ex-date at 0.17%. Yield at the ex-date is a historical calculation based on the dividend and the market price around that date, rather than a guaranteed annual return.

The company stated that payment of this interim dividend would begin from 26 August 2026. An interim dividend is approved by the board during a financial year and does not require shareholders to wait for the annual dividend decision.

Which shareholders were eligible for the ₹1.50 dividend?

Shareholders eligible for the dividend were those recorded as members or beneficial owners on 20 August 2026, the record date set by Natco Pharma. The ex-date was also 20 August 2026, according to the dividend history provided.

The record date is important because it determines which investors are entitled to receive the distribution. Investors who bought shares after the applicable ex-date would generally not be eligible for this particular payment, while shareholders holding the shares in the relevant records on the record date would qualify.

How does the FY2027 payout compare with earlier dividends?

Natco Pharma's ₹1.50 FY2027 interim dividend matches the ₹1.50 distributions declared in February 2026 and November 2025. The company had declared ₹2 per share in August 2025, while the dividend history also shows a ₹1.50 second interim dividend in November 2024.

The supplied history covers 41 dividend declarations, with older payouts including ₹1.25 per share in November 2023, ₹0.75 per share in November 2022 and ₹1 per share in November 2019. Historical entries should be read carefully because dividend frequency, types and prevailing share prices can change between periods.

For FY2025, the company had declared a second interim dividend of ₹1.50 per share in November 2024. Its record date was subsequently revised to 27 November 2024, and the company said payment would start from 4 December 2024. This illustrates that shareholders should refer to the latest exchange disclosures for any revisions to dates.

What do Natco Pharma's recent disclosures say about another dividend?

Natco Pharma has informed exchanges that its board meeting on 13 November 2026 would consider unaudited financial results for the quarter and half year ended 30 September 2026, along with a possible second interim dividend for FY2027. The disclosure states that the board would consider a declaration, not that a second dividend had already been approved.

The August 2026 announcement had similarly followed a board-meeting intimation dated 6 August 2026, which said the board would consider the June-quarter results and an interim dividend. The subsequent 14 August decision resulted in the ₹1.50 per-share declaration.

For financial context, Natco Pharma reported consolidated total revenue of ₹1,434.9 crore for the September 2024 quarter, compared with ₹1,060.8 crore in the corresponding prior-year period. Consolidated net profit was ₹676.5 crore versus ₹369.0 crore. These figures relate to FY2025 and should not be treated as current FY2027 financial performance.

What does the announcement mean for investors and the market?

For eligible holders, the announcement defined a cash distribution of ₹1.50 per share and the date on which eligibility was determined. The stated 0.17% yield at the ex-date provides a point-in-time measure of the immediate payout relative to the share price, but it does not represent a full-year dividend yield.

For investors assessing Natco Pharma's dividend record, the important considerations are the amount per share, the timing of board approvals and the company's future financial disclosures. The available data shows repeated interim dividend declarations, but it does not establish a fixed dividend policy or a commitment to any future payout amount.

The 13 November 2026 board meeting is relevant because the board was scheduled to review the September-quarter and first-half results as well as a potential second interim dividend. Any actual declaration, dividend amount, record date or payment timeline would depend on the board's decision and subsequent exchange filing.

Conclusion

Natco Pharma's latest confirmed dividend was an interim payout of ₹1.50 per share for FY2027, declared on 14 August 2026. The 20 August 2026 ex-date and record date determined eligibility, while payment was scheduled to begin on 26 August 2026. The payout matched the company's ₹1.50 interim dividends declared in February 2026 and November 2025.

Investors should watch the outcome of the 13 November 2026 board meeting, where Natco Pharma was scheduled to consider September-quarter and half-year results and a possible second interim dividend. The company had not, in the provided disclosures, confirmed the approval or amount of that potential dividend.